5 Biotech Stocks to Buy Now

• «
• »

Biotech Stock 1 - Cougar Biotechnology, Inc. (CGRB)

Founded in 2003 before the cougar craze became a national phenomenon, Cougar Biotechnology (CGRB) specializes in cancer treatments. The company has a number of drugs in various stages of trial, including treatments for prostate cancer, breast cancer and multiple myeloma.

Last week the company announced that it had lost $23.3 million or $1.12 per share in the first quarter ending March, 31, 2009. The results were worse than the expected loss of $.94 per share. Higher expenses for stage three trials of its prostate treatment were to blame for the bigger loss. It is quite expensive to bring a new drug to market. Fortunately, Cougar is that much closer to seeing its prostate cancer drug through clinical trials. And with more than $75 million in cash remaining on the balance sheet, CGRB is an attractive investment option.

I rate the stock a B or Buy.

Next: Biotech Stock 2 - Cephalon, Inc.